The Trump administration this week scrapped a key proposal that would have eliminated pharma-PBM rebates in Medicare, an effort aimed at reducing prescription drug prices, the Washington Post reports.
According to the report, the the administration’s decision to pull the plug on the proposal signals the turmoil involved with efforts to find solutions to high drug prices.
“Based on careful analysis and thorough consideration, the President has decided to withdraw the rebate rule,” Judd Deere, White House spokesman, said in a statement Thursday. “The Trump administration is encouraged by continuing bipartisan conversations about legislation to reduce outrageous drug costs imposed on the American people, and President Trump will consider using any and all tools to ensure that prescription drug costs will continue to decline.”
Fierce Healthcare reports that Trump is in the coming weeks expected to unveil a new proposal also aimed at reducing how much the U.S. pays for prescription drugs.
To read more on the Washington Post, click here.